Form D - Notice of Exempt Offering of Securities:
SEC Accession No. 0001641172-25-003977
Filing Date
2025-04-14
Accepted
2025-04-14 09:48:04
Documents
1
Effectiveness Date
2025-04-14
Items
Item 06b:

Document Format Files

Seq Description Document Type Size
1 primary_doc.html D  
1 primary_doc.xml D 11377
  Complete submission text file 0001641172-25-003977.txt   12658
Mailing Address 7946 IVANHOE AVENUE SUITE 201 LA JOLLA CA 92037
Business Address 7946 IVANHOE AVENUE SUITE 201 LA JOLLA CA 92037 (858) 263-4196
Ensysce Biosciences, Inc. (Filer) CIK: 0001716947 (see all company filings)

EIN.: 822755287 | State of Incorp.: DE | Fiscal Year End: 1231
Type: D | Act: 33 | File No.: 021-543546 | Film No.: 25834415
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)